Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer

NCT05926284 · tracked via the Priya Life Science Germany tracker

Sponsor

Charite University, Berlin, Germany

Phase

Observational

Started

2016-03-01

Last updated

2023-07-03

Condition(s) studied

Cancer

Study summary

Prospective observational study of a precision medicine approach in patients with advanced cancer. In this registrational study, patients with advanced cancer undergoing extensive molecular sequencing within the precision oncology program of Charité University Medicine, Berlin will be registered and followed to assess the efficacy of the program and assess the clinical relevance and frequency of molecular alterations, individualized therapies and novel molecular analysis tools.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * advanced cancer * ability to give written informed consent * performance status allows initiation of a potential targeted treatment after molecular analysis * molecular analysis has been done or planned Exclusion Criteria: \- unable to give written informed consent

Primary outcome measure(s)

Frequency of personalized treatment initiation — At 1 year from date of study inclusion
Frequency of personalized treatment initiation
Frequency of molecularly stratified treatment options — At 1 year from date of study inclusion
Number of molecularly stratified treatment options per patient

Trial sites (1)

Facility	City	Region	Status
Charité Comprehensive Cancer Center	Berlin	Germany	Recruiting

More Charite University, Berlin, Germany trials in Germany

Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE) Starting soon

Berlin-Brandenburg Pregnancy Cohort Recruiting

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture Recruiting

Quality Contract: Prevention of Postoperative Delirium in the Care of Older Patients (QV-POD-2) Recruiting

Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer Starting soon

Other trials for the same condition

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases Recruiting

Pan Tumor Rollover Study Recruiting

Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries. Recruiting

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor Active, not recruiting

Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05926284 on ClinicalTrials.gov ↗ ← All trials in Germany